Evidence-based recommendations on the bisphosphonates alendronic acid, ibandronic acid, risedronate sodium and zoledronic acid for treating osteoporosis
4 results for Ibandronic acid
Summary of the evidence on adjuvant bisphosphonates for preventing recurrence or improving survival in people with early breast cancer
Everything NICE has said on assessing the risk of, preventing and treating osteoporotic fragility fractures in adults in an interactive flowchart
NICE has published new guidance on the use of drugs called bisphosphonates for preventing bone fractures in people at increased risk.